Patent · US Active

Compounds for RNA capping and uses thereof

US12060385B2 · kind B2 · utility

0Cited by
0References
29Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 3, 2023
Grant dateAug 13, 2024
Priority date
Expiry dateJul 3, 2043

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02P20/55
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present disclosure relates to compounds for RNA capping and uses thereof, which belong to the technical field of genetic engineering. Compounds of formula I can result in high levels of capping efficiency, and the capped mRNA exhibits a high transcription level and increased expression.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.